Navigation Links
Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs
Date:3/11/2010

utics Inc. is a private biopharmaceutical company specializing in innovative therapies of immune-mediated conditions, such as autoimmune and inflammatory disorders, as well as cancer. The company's lead program, TTI-1612, is a recombinant growth factor that is being developed for the treatment of interstitial cystitis (IC) and the prevention of necrotizing enterocolitis (NEC). Trillium has broad portfolio preclinical immunology programs, including two partnered programs that target the CD200 immunoregulatory axis; a CD200-specific monoclonal antibody for the treatment of cancer, and a CD200Fc fusion protein for the treatment of autoimmune and inflammatory diseases. In addition, the company has an FcgRIIa-specific humanized monoclonal antibody in development for treatment of immune complex-mediated inflammatory diseases.

The company has a broad network of external academic and industry R&D collaborations, including several license agreements with major US biotechnology companies. The Company is supported by three premier venture capital investors: Vengrowth Private Equity Partners, Growthworks Capital and BDC Capital.

SOURCE Trillium Therapeutics Inc.

Back to top
'/>"/>
SOURCE Trillium Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Trillium adds industry veteran Dr. Mike Gresser to its Board of Directors
2. Trillium and Biogen Idec enter into global license agreement
3. Trillium Strengthens its Board of Directors
4. Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway
5. Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California
6. BioMed Realty Trust Expands Lease With Ironwood Pharmaceuticals for 50,000 Square Feet in Cambridge, Massachusetts
7. Laboratory Products Leader Sterlitech Expands RO Membranes Line
8. Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development
9. Progenitor Cell Therapy Expands Manufacturing Operations
10. Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma
11. Wound Management Technologies, Inc. Rapidly Expands Its International Presence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Research and Markets has ... Diagnostics Market (Product types, Application, Technology, End User ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation ... their offering. This new report ... users and Geography) Global Size, Industry Analysis, Trends, ...
(Date:10/22/2014)... October 22, 2014 Involution Studios ... release of a new infographic, Understanding Ebola . ... a beautifully designed, easy to follow informative tool for ... of outbreak, symptoms and prevention. , "As the news ... the 2014 Ebola outbreak represents not only a healthcare ...
(Date:10/22/2014)... According to new market research report ... Integration, Deployment & Support), by Service Model (SaaS, ... Others (Hybrid & Community)) - Global Forecast to ... Cloud Professional Services Market into various sub-segments with ... also identifies the drivers and restraints for this ...
(Date:10/22/2014)... and HONG KONG , Oct. 22, ... therapeutics enterprise, announced today that rare disease expert ... vice president, research. Dr. McKew brings more than two ... positions at the National Institutes of Health, Wyeth Research ... Wyeth). Dr. McKew will lead aTyr,s efforts to expand and ...
Breaking Biology Technology:Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
... June 29 The California Department of Labor today ... million grant to implement new workforce training programs for ... Initiative, a collaborative effort including CleanTECH San Diego, BIOCOM, San ... and the San Diego Workforce Partnership, captured the grant through ...
... SAN DIEGO , June 29 ... key commercialization milestones ahead of schedule. First, the company ... and commercial viability of a ,green, version of 1,4-butanediol ... confirmed the accelerated development time and reduced development and ...
... June 29, 2010 , , , ... it Will Carry the Disease and Therapy,Review: Impetigo Market Research Report in its Store. ... Browse the complete Report on:, http://www.reportsandreports.com/market-reports/disease-and-therapy-review-im ,petigo/ , ... The Impetigo Disease and Therapy Review provides an overview ...
Cached Biology Technology:San Diego Region Awarded $4 Million Workforce Development Grant to Support Expanding Biofuels Industry 2San Diego Region Awarded $4 Million Workforce Development Grant to Support Expanding Biofuels Industry 3San Diego Region Awarded $4 Million Workforce Development Grant to Support Expanding Biofuels Industry 4Genomatica Delivers Pilot-Scale Validation in Sustainable Chemical Manufacturing 2Genomatica Delivers Pilot-Scale Validation in Sustainable Chemical Manufacturing 3Genomatica Delivers Pilot-Scale Validation in Sustainable Chemical Manufacturing 4Disease and Therapy Review: Impetigo Now Available at ReportsandReports 2Disease and Therapy Review: Impetigo Now Available at ReportsandReports 3Disease and Therapy Review: Impetigo Now Available at ReportsandReports 4Disease and Therapy Review: Impetigo Now Available at ReportsandReports 5
(Date:10/25/2014)... --  MedNet Solutions , a global life sciences technology ... to announce the 2014 iMedNet User Group ... in Bloomington, Minnesota on October ... and promises to be informative, productive and enjoyable for ... meeting is iMedNet™ EDC , MedNet,s ...
(Date:10/25/2014)... This report covers the specifics of microRNA ... heavy pursuit of research due to its versatility and ... other RNA components. miRNA,s non-coding nature and ability to ... use as a biomarker for a variety of diseases. ... for the advancement in therapeutic development. Furthermore there are ...
(Date:10/25/2014)... -- A recent report, "Genetic Testing Market Outlook 2018", ... genetic testing market. A comprehensive introduction of gene-based tests, ... report. On account of our analysis of the past ... challenges; forecast for genetic testing has been drawn, according ... a CAGR of around 9% during 2013-2018. Our ...
Breaking Biology News(10 mins):MedNet Solutions To Host Third Annual iMedNet User Group Meeting 2MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Genetic Testing Market Outlook 2018 2
... Scientists at St. Jude Children's Research Hospital have announced ... against one antigenic variant of the avian influenza virus ... virus. Vaccines based on this model might therefore be ... epidemic) until a new vaccine could be developed specifically ...
... half of human cancers involve mutations in the p53 ... normal p53 protein in defending against cancer. Similarly, roughly ... occur in its DNA-binding core domain, pointing to this ... its anti-cancer activity. , Clearly, a detailed view of ...
... a lifetime of daily injections to replace the ... as a host of risks that includes blindness, ... particularly those afflicted with juvenile diabetes, transplants of ... might alleviate these problems. Unfortunately, there are not ...
Cached Biology News:Scientists to employ Arctic ice and polar bears to protect diversity of world's crops 2Structure determined for p53 tumor suppressor protein as bound to DNA for anti-cancer activity 2Successful transplantation from pig embryos to mice 2
... I can be used in intracellular staining ... cells and to serve as an antibody ... cell permeabilization is a reversible process, it ... the presence of saponin during intracellular staining. ...
... raised against a partial recombinant ... PPP4C (NP_002711, 218 a.a. ... protein with GST tag. ... NM_002720 Protein ...
... Eppendorf Thermomixer R offers maximum application ... shaking, heating, and cooling. Its active ... application and temperature control ranges. Five ... 24 micro test tubes, are available ...
Mouse monoclonal antibody raised against a partial recombinant PDE2A. NCBI Entrez Gene ID = PDE2A...
Biology Products: